Home2020/04 April 15, 2020 -

https://mysicklefamilyllc.com/wp-content/uploads/2020/04/shutterstock_318128108-1-1000x480-1000x480-1.jpg

The intentional practice of gratitude is an essential life skill that’s helped me endure the toughest situations. A couple of years ago, my health went through a really tough period. I thought I knew everything about managing sickle cell but everything seemed to go wrong. I was regularly experiencing high crisis pain, which heavily interfered with my responsibilities — this had me feeling down for a very long time. The Gratitude Jar Challenge. Thankfully I...

https://mysicklefamilyllc.com/wp-content/uploads/2020/04/shutterstock_598486442_zpsagenm5r0-1280x720.jpg

The Phase 2 STRONG-SCD trial evaluating olinciguat as a potential oral therapy for sickle cell disease is completely enrolled, Cyclerion Therapeutics said. Seventy patients with stable disease were recruited, and topline results are expected between July and September. The company is not expecting the supply of olinciguat needed for STRONG-SCD to be affected by the COVID-19 pandemic, although other limitations to the study are possible. “We are excited to have closed enrollment for our SCD-STRONG...